tirzepatide safety profile after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide for Medical Weight Loss

Getting the right diagnosis early can make a significant difference to your outcome

Microbial metabolism affects systemic homeostasis and remodels the TME via metabolites, affecting tumour angiogenesis, metabolism, and EMT (182, 183)

What protects you is recognizing severe, persistent abdominal pain, stopping the drug, and getting evaluated, which is the same advice given to every patient regardless of risk level

The initial studies towards exploring the radioprotective activity of DSePA were carried out using in vitro models

Lixisenatide has a simple one-step dose increase and a single maintenance dose of 20 g OD for all patients